Oral tablets with 5-alpha reductase inhibitor, applied in urology departments and primary care facilities for benign prostatic hyperplasia treatment. Produced by generic and branded pharmaceutical firms, procured by hospitals, retail pharmacies, and distributors for ongoing patient therapy in men's health